Dr. Qingsong Zhu is the Chief Operating Officer of Insilico Medicine, Inc. and is responsible for Insilico Medicine operations and drug development. He obtained his Ph.D. degree from Kansas State University in biochemistry. Dr. Zhu received his postdoctoral training at Johns Hopkins under the supervision of Dr. Nancy Davidson in breast cancer field. He has over 12 years of experience in genomics research and drug development. His latest entrepreneurial endeavors focused on improving the early diagnosis and personalized treatment of cancer and other age-related diseases.
Sessions I’m Presenting
|Affiliation||Insilico Medicine, Inc.|